A Prion in yeast Huntington's disease
Huntingtin-like proteins make yeast sick (bottom).
eriin et al., reporting on page 997, have developed the first yeast model for studying Huntington's disease. Yeast cannot undergo neurodegeneration, of course, but the simplicity and genetic manipulability of the system are already providing important mechanistic insights. The authors report that aggregation of a polypeptide with an expanded polyglutamine domain, mediated by a prion-like protein, is responsible for cell death in their system, suggesting revisions to earlier models of neurodegeneration.
In Huntington's disease, expansion of the huntingtin polyglutamine domain leads to protein aggregation in inclusion bodies and neuronal cell death. In some systems, however, long polyglutamine peptides are toxic without aggregating, suggesting that aggregation of mutant huntingtin might not determine toxicity. Meriin and colleagues found, however, that aggregation of long polyglutamine peptides in yeast correlated with toxicity. Mutations in certain chaperone M genes, or curing the cells of the prion form of the Rnq1 protein, suppressed both aggregation and toxicity.
The results directly link polyglutamine peptide aggregation with cell death, and demonstrate that prion proteins are required for this process, at least in yeast. The evolutionary conservation of these mechanisms suggests that prion-like proteins might also be involved in mammalian polyglutamine expansion diseases.
How fish oils work
or years, epidemiologists and nutritionists have known that a diet high in the v-3 fatty acids found in fish oil correlates with a decreased risk of colon cancer. On page 915, Murray et al. explain why.
As colon carcinogenesis is accompanied by an increase in the expression of the lipiddependent protein kinase C ␤ II (PKC ␤ II), the authors reasoned that -3 fatty acids might inhibit PKC ␤ II signaling. Analysis of rat colonic epithelia and PKC ␤ II transgenic mice demonstrated that -3 fatty acids block F -3 (right), but not -6 (left), fatty acids restore TGF␤RII expression.
PKC ␤ II activation and reduce the pro-carcinogenic effects of PKC ␤ II in vitro and in vivo. PKC ␤ II appears to repress the expression of transforming growth factor ␤ receptor II (TGF ␤ RII), desensitizing cells to the growth-inhibiting effects of TGF ␤ .
The results suggest that -3 fatty acids inhibit PKC ␤ II, thus relieving the inhibition of TGF ␤ RII expression. This renders colon epithelial cells sensitive to TGF ␤ , and prevents or reverses the hyperproliferative state that leads to colon cancer. Dietary -3 fatty acids are also associated with preventing prostate and breast cancer and some neurological conditions, suggesting that PKC ␤ II may be a promising target for multiple chemoprevention strategies.
A vitamin makes minerals
rowth plate chondrocytes help turn cartilage into bone by releasing specialized matrix vesicles, which contain the crystaline seeds for calcification. On page 1061, Wang and Kirsch show how retinoic acid (vitamin A) controls this process of mineralization.
Previous work showed that retinoic acid stimulates mineralization and induces the formation of matrix vesicles, but its molecular targets remained unknown. In the new study, the authors found that, in cultured growth plate chondrocytes, retinoic acid acts by increasing the transcription of three annexin family proteins and causing them to form calcium channels in the plasma membrane.
Retinoic acid is known to regulate transcription after binding to the retinoic acid receptor complex, but the new results imply that it can also control calcium homeostasis, perhaps through receptors yet to be discovered. After retinoic acid induces an initial calcium influx, the formation of induced annexins into channels in the plasma membrane further boosts cytosolic calcium, increasing annexin expression again and causing the release of matrix vesicles. These vesicles contain annexin channels that allow the entry of crystal-forming calcium.
Excess mineralization has been implicated in several disease processes, including osteoarthritis and the calcification of cardiovascular tissues. Recently, the authors have determined that annexin expression is induced in osteoarthritic chondrocytes. If annexins are as central to pathogenic mineralization as they appear to be in healthy tissue, they could be promising targets for a variety of therapies.
G
Vitamin A induces bone mineralization.
